Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi Drug Resistant Tuberculosis”

130 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 130 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableEnded earlyNCT01381757
What this trial is testing

Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali

Who this might be right for
Tuberculosis, PulmonaryMycobacterium TuberculousAntitubercular Agents+3 more
National Institute of Allergy and Infectious Diseases (NIAID) 34
Testing effectiveness (Phase 2)Study completedNCT02906007
What this trial is testing

Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV

Who this might be right for
TuberculosisHIV
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableUnknownNCT02496572
What this trial is testing

Effectiveness of a Simplified Short Regimen for Multidrug Resistant Tuberculosis in Uzbekistan

Who this might be right for
Multidrug Resistant Tuberculosis
Medecins Sans Frontieres, Netherlands 110
Large-scale testing (Phase 3)UnknownNCT02120638
What this trial is testing

Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 100
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Looking for participantsNCT05824871
What this trial is testing

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

Who this might be right for
Rifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)
Shanghai Jiatan Pharmatech Co., Ltd 450
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableUnknownNCT04484129
What this trial is testing

MDR-TB Close Contacts Tracing in China (TCCT Study)

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 500
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Post-approval studies (Phase 4)Study completedNCT03830671
What this trial is testing

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Beijing Chest Hospital 515
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableStudy completedNCT04928378
What this trial is testing

Bone Resistant Tuberculosis

Who this might be right for
Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
Assistance Publique - Hôpitaux de Paris 23
Large-scale testing (Phase 3)Study completedNCT02409290
What this trial is testing

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
MDR-TB
IUATLD, Inc 588
Large-scale testing (Phase 3)Study completedNCT03896685
What this trial is testing

Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Who this might be right for
Tuberculosis, Multidrug-ResistantTuberculosisPulmonary Tuberculoses+3 more
Médecins Sans Frontières, France 323
Not applicableStudy completedNCT05175794
What this trial is testing

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Who this might be right for
Drug Resistant TuberculosisMDR-TBXDR-TB+1 more
Centre for the AIDS Programme of Research in South Africa 786
Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Post-approval studies (Phase 4)Study completedNCT01521364
What this trial is testing

Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients

Who this might be right for
Multidrug-resistant TuberculosisExtensively Drug-resistant Tuberculosis
University Medical Center Groningen 7
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT02365623
What this trial is testing

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Pharmaceutical K.K. 6
Load More Results